-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_executive.pdf
June 01, 2013 - involves implantation of an indwelling
device that is not reversible, it is considered a treatment of
last … all 3 studies found that patients in the procedure arm had a
significantly lower heart rate at 12 months … addition to transcatheter PVI showed a potential
benefit in the maintenance of sinus rhythm at
12 months … 2006 guidelines jointly issued by the ACC, AHA, and
ESC have guided most management of AF for the last … ablation and pacemaker implantation needs to be
better defined, given that this procedure is one of last
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-noninvasive-nonpharma.pdf
April 01, 2022 - inflammation)
• Other nonclinical outcomes
Timing Duration of followup: short term (1 to
<6 months … ), intermediate term (≥6 to
<12 months) and long term (≥12
months); focus on longer term (>12
month … Trials lasting ≥6 months that include a
supervised intervention followed by
continued home treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
October 01, 2007 - We restricted cohort 1 to incident statin users,
defined as no statin use in the 12 months before the … glaucoma medications (�30 days), with no use of
a glaucoma medication or a statin in the preceding 12 months … transitory ischemic
attack, MI, arterial surgery, or amputation for vascular dis-
ease in the past 6 months … During 12 months of follow-up, 3.6% of matched
nonusers initiated a statin during follow-up; 3.8% of … 2, October 2007
© 2007 Lippincott Williams & WilkinsS138
How closely did our analysis after the last
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/ems-911-workforce-protocol.pdf
January 01, 2015 - We will limit the search to the last 15 years because
older studies have little relevance to modern … The dispositions of the peer review comments are documented
and may be published three months after
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
December 01, 2009 - an exacerbation that resulted in a
hospitalization or at least two outpatient exacerbations in the last … 12 months. … Covariates
We defined covariates from the 12 months preceding the index date. … baseline and had a slightly larger percentage with 3 or
more outpatient visits in the preceding 12 months
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
December 29, 2020 - Each generation has worse symptoms
than the last. The collagen in our bodies
does not work well. … The spinal injections do not work for me
and they do not last more than a week, if
at all. … have from the
doctor a "As needed opioid medication for
times when the extended release did not
last … He knew
everything about me and I saw him every
three months. … for 6 months.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-pharm-non-pharm-treatment-update-disposition-comments.pdf
August 28, 2024 - the authors’ responses to the comments are posted for
public viewing on the Web site approximately 3 months … We have clarified that
this last paragraph
summarizes key
points from the report. … section on page 1 to provide some VERY
BRIEF history of the PTSD repository and the duration
since last
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - depending on expert comments received on interventions issued for
comment during the preceding 6 months … The Reshape Duo is designed to be kept in the stomach for
6 months and then removed, using an endoscopic … weight loss.4 In February
2013, the company announced it had completed study enrollment within 6 months … top-dose as compared
to -1.8% for the placebo group (lease-squares mean ITT-LOCF [intention to treat–
last … (37.5%; p<0.001)
or lorcaserin QD (44.7%; p<0.001) vs. placebo (16.1%; modified intent to
treat/last
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
January 30, 2013 - of biomarkers in screening and diagnosing PAH has been the subject of
increasing interest over the last … infection, site pain, abrupt catheter
occlusion)
• Timing:
o Intermediate-term (≤120 days, 4 months … , 16 weeks are the usual time points for the
efficacy studies)
o Long-term (>120 days, 4 months, 16 … included studies, we will indicate the total number of patients enrolled and longest length (weeks or months … the peer review comments are documented and will, for
CERs and Technical briefs, be published three months
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
October 22, 2012 - aimed at assessment of cough in adults10,11 and one focused on children.12 Guidelines from
the ACCP, last … included studies, we will indicate the total number of patients enrolled and longest length (weeks or months … the peer review comments are documented and will, for
CERs and Technical briefs, be published three months
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
March 01, 2017 - sex standardized
prevalence of dementia and the rates of
incident dementia have fallen over the
last … However, since the review is focused on prevention, studies
must be at least 6 months in duration to … and/or MCI, used a
comparator group, and reported outcomes of interest in
participants at least 6 months … The Burden of Health Care
Costs for Patients With Dementia in the Last 5 Years of LifeBurden
of Health
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
March 01, 2017 - sex standardized
prevalence of dementia and the rates of
incident dementia have fallen over the
last … However, since the review is focused on prevention, studies
must be at least 6 months in duration to … and/or MCI, used a
comparator group, and reported outcomes of interest in
participants at least 6 months … The Burden of Health Care
Costs for Patients With Dementia in the Last 5 Years of LifeBurden
of Health
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-nerve-blocks-disposition-comments.pdf
August 15, 2025 - the authors’ responses to the comments are posted
for public viewing on the website approximately 3 months … We can’t expect a
drug effect from an LA that does not last 24
hours. … Medical Center
Conclusion As mentioned above, based on 25+ years
doing neuraxial blocks and for the last
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - responses to the comments are posted for
public viewing on the EHC Program Web site approximately 3 months … Gans-Brangs,
Kathleen
(AstraZeneca)
Executive
Summary
Page ES28, last bullet. … Page 188-9 Last sentence on page 188
states that the cost-effectiveness of ticagrelor is not known. … Bleeding at 3 months was not a primary
endpoint. … The numbers shown for composite efficacy endpoint at
30 days and 3 months are for CV death/MI/stroke
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
March 01, 2013 - nonpregnant women from menarche to menopause who
have had abnormal bleeding (scant or heavy) for 3 months … • Abnormal cyclic uterine bleeding: problem bleeding of 3 months or greater duration, excluding irregular … weight gain, short- and long-term harms)
Timing: Interventions initiated after symptoms present most months … for 3 months or longer. … Study duration was typically 6 months or less.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
January 30, 2012 - This project will focus on the last area. … recurrent episodes that self-terminate in less than 7 days),
persistent AF (recurrent episodes that last … recurrent episodes that self-
terminate in less than 7 days)
o Persistent AF (recurrent episodes that last … included studies, we will indicate the total number of patients enrolled and the longest length (weeks or months … of the peer review comments are documented and will, for
CERs and Technical briefs, be published 3 months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
May 21, 2015 - Psychiatric treatment has
changed significantly in the last 15 years. … .,
in Findings, under the initial
description of “Alternatives
to Psychiatric
Hospitalization”, last … days) and to 1.89 from seven to 12
months (2,304 hospitalization days). … These data represent a 46%
decrease in hospitalizations across 18 months. … A treatment condition
(three groups) × time (baseline, six months, and 12 months) repeated-
measures
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
December 01, 2015 - -5 defines insomnia disorder as
occurring when sleep problems and
associated distress/dysfunction last … longer than 3 months.4
Effective
Health Care
Effective Health Care Program
2
Between 6 and … Timing
● Key Question 1: Outcomes measured at 4 weeks to
3 months after initiation of treatment were … Several studies required a minimum symptom
duration ranging from 4 weeks to 6 months. … Insomnia
duration ranged from 6 months to 19 years in trials
reporting insomnia duration.
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
April 01, 2021 - Duplication
We searched for high-quality, completed or in-process evidence reviews published in the last … Feasibility of New Evidence Review
We conducted a limited literature search in PubMed for the last … care) or routine or service or services or schedul* or visit*).ti. (174)
3 and/1-2 (7)
4 limit 3 to last … media" or skype or technology* or video* or virtual* or web).ti. (126)
6 and/1,5 (1)
7 limit 6 to last
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
March 01, 2013 - For questions related to the efficacy of diet therapy,
we included RCTs of at least 12 months duration … For questions related to the efficacy of pharmacological
therapy, we included RCTs of at least 12 months … least 100 patients
being treated to prevent recurrent kidney stones, with
a minimum duration of 3 months … efficacy data, or from prospective cohort studies at least
3 months in duration. … Last, very few trials reported
symptomatic stone recurrence as an isolated efficacy
outcome, and almost